SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst intense public debate following a controversial incident in Minnesota involving federal agents and the death of an American citizen. Community discussions are sharply polarized, with many condemning the actions of law enforcement as unjust, while others defend the agents and criticize protestors. This political flashpoint, linked to broader conversations about civil liberties and government authority, is significantly influencing sentiment around the stock.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to reports of a significant U.S. government investment package and a new metal and alloy production facility in France, backed by substantial French government support, bolstering its integrated supply chain strategy. The community is buzzing with excitement, comparing this to prior rallies in the rare earth sector driven by similar government involvement, as global demand for critical minerals and domestic sourcing intensifies. This strategic expansion is fueling discussions around the company's long-term growth and its role in securing key resources.

Zoracles

ZORACoin is trending as the community anticipates a significant market reversal and an "Altcoin Season," driven by expectations of potential FED rate cuts, increased liquidity, and forthcoming regulatory clarity from events like the Clarity Act. Many holders express conviction in its long-term potential within the creator economy, noting its connection to the Coinbase Base ecosystem and its recent status update from an experimental asset. While some express frustration over prior stagnation and perceived market manipulation, a strong undercurrent of optimism persists for a notable breakout.

Honeywell International, Inc. is a software industrial company, which offers industry specific solutions to aerospace and automotive products and services. It operates through the following business segments: Aerospace Technologies, Industrial Automation, Building Automation, Energy and Sustainability Solutions, and Corporate and All Other. The company was founded by Albert M. Butz in 1906 and is headquartered in Charlotte, NC.

Honeywell International Inc

Honeywell is trending as its majority-owned quantum computing unit, Quantinuum, is reportedly preparing for an IPO, following a significant investment round that included Nvidia. This news, coupled with recent analyst upgrades and ongoing enthusiasm for its multi-part breakup strategy, has the community buzzing about potential value creation and a long-awaited breakout similar to successful industrial spin-offs.

Smith & Wesson Brands, Inc. is a holding company, which engages in the manufacture, design, and provision of firearms. Its portfolio includes handguns, long guns, handcuffs, suppressor, and other firearm-related products. The firm's brands are Smith & Wesson, M&P, Thompson/Center Arms, and Gemtech. The company was founded by Horace Smith and Daniel Baird Wesson in 1852 and is headquartered in Maryville, TN.

Smith & Wesson Brands Inc

Smith & Wesson Brands is a trending topic, primarily driven by community discussions around perceived escalating civil unrest and political tensions, which many believe will boost firearm sales. This sentiment is further fueled by reports that the Justice Department is considering easing gun regulations and the rescission of strict firearm export controls. Despite a recent earnings report showing some macroeconomic headwinds, investors are weighing these potential catalysts against the current valuation.

Harley-Davidson, Inc. is engaged in the manufacture and sale of custom, cruiser, and touring motorcycles. It operates through the following segments: Motorcycles & Related Products and Financial Services. The Motorcycles & Related Products segment manufactures, designs, and sells at wholesale on-road Harley-Davidson motorcycles as well as motorcycle parts, accessories, general merchandise, and related services. The Financial Services segment consists of financing and servicing wholesale inventory receivables and retail consumer loans, primarily for the purchase of Harley-Davidson motorcycles. The company was founded by William Sylvester Harley, Arthur Davidson, Walter C. Davidson, Sr. and William A. Davidson in 1903 and is headquartered in Milwaukee, WI.

Harley-Davidson, Inc.

Harley-Davidson is heavily discussed as it navigates a polarized community reaction to its corporate strategy, specifically a recent public retraction of past diversity initiatives. This unfolds amidst mixed financial reports, ongoing challenges from tariffs and inventory, and a significant financial services deal aimed at bolstering its balance sheet. Sentiment is divided between those critical of leadership decisions impacting brand identity and others who foresee potential for a turnaround with new product releases and strategic financial moves.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

Mawson Infrastructure Group is garnering significant community attention following its regained Nasdaq compliance and a lawsuit seeking substantial damages for a past bad-faith bankruptcy filing. Investors are actively discussing the company's strategic pivot to AI and high-performance computing, leveraging its valuable power infrastructure, leading to strong beliefs of undervaluation and potential for a short squeeze amid increased insider accumulation.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is garnering significant attention following multiple strategic moves, including a key licensing deal with Janux Therapeutics for a novel cancer therapy and a partnership with Microsoft to integrate AI for lung cancer detection. These collaborations, alongside positive data for its cardiovascular drug Camzyos and the acquisition of Orbital Therapeutics, are seen by the community as crucial steps in strengthening its pipeline amid industry patent challenges. The market is closely watching how these developments position the pharmaceutical giant for future growth, especially with upcoming earnings on the horizon.

PENN Entertainment, Inc. engages in the provision of integrated entertainment, sports content, and casino gaming services. It operates through the following business segments: Northeast, South, West, Midwest, Interactive, and Other. The Northeast segment includes Ameristar East Chicago, Hollywood Casino, Hollywood Gaming, Marquee, and Plainridge Park Casino operations. The South segment manages 1st Jackpot Casino, Ameristar Vicksburg, Boomtown, Hollywood Casino Gulf Coast, Hollywood Casino Tunica, L’Auberge, and Margaritaville Resort Casino. The West segment is involved in Ameristar Black Hawk, Cactus Petes and Horseshu, M Resort Spa Casino, and Zia Park Casino operations. The Midwest segment focuses on Ameristar Council Bluffs, Argosy Casino, Hollywood Casino, Prairie State Gaming, and River City Casino operations. The Interactive segment refers to an online gaming portfolio which includes ESPN BET, Hollywood Casino, theScore Bet, and PENN Game Studios. The Other segment consists of stand-alone racing operations, namely Sanford-Orlando Kennel Club, Sam Houston, and Valley Race Park. The company was founded by Peter M. Carlino in 1982 and is headquartered in Wyomissing, PA.

PENN Entertainment Inc

PENN Entertainment Inc.

PENN Entertainment is trending following its decision to end the ESPN Bet partnership early, rebranding its U.S. online sportsbook to theScore Bet and signaling a strategic refocus on its iCasino business and regional casino assets. This move has intensified community debate, with many investors calling for new leadership and questioning past digital strategy, while some analysts and long-term holders see potential for improved profitability and shareholder value from the restructuring and strong regional casino performance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is currently trending due to compelling long-term data for its partnered melanoma vaccine, which continues to show sustained efficacy in reducing cancer recurrence. This positive clinical news, alongside strategic pipeline advancements and recent acquisitions to diversify its portfolio, is generating significant investor conversation. The community is actively discussing how these moves position Merck for future growth, particularly in oncology and new blockbuster therapies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The biotech sector is already buzzing with retail investor interest as the new year begins. Here’s a look at the top three biotech stocks driving conversations on Stocktwits based on message volume jumps on the first trading day of 2025:Carmell Corp (CTCX): +58,100% Message VolumeRegenerative medicine biotech Carmell Corp surged into the spotlight after announcing an acquisition deal with PMGC Holdings’ Elevai Skincare subsidiary. The transaction includes $1.1 million in Carmell stock, $57,000 in cash, and contingent earnouts linked to Elevai’s product sales and revenue milestones.&nbsp;Carmell expects to acquire Elevai’s skincare and haircare portfolio, including a commercial team and inventory with $2.5 million in trailing revenue.&nbsp;Shares rocketed 148% on Thursday but saw some profit-taking early on Friday. Carmell’s stock lost roughly 80% last year.Mustang Bio (MBIO): +27,200% Message VolumeMustang Bio shares climbed 18% on Thursday and gained further in Friday’s pre-market, despite no apparent catalyst.&nbsp;In November, the company secured an extension from Nasdaq to meet compliance requirements and received FDA Orphan Drug Designation for MB-108, an oncolytic virus treatment for malignant glioma.&nbsp;While the stock fell nearly 85% in 2024, recent developments have sparked renewed optimism among investors.Revelation Biosciences (REVB): +9,150% Message VolumeRevelation Biosciences rose 42% on Thursday before sliding in Friday’s pre-market session without any catalyst.&nbsp;Retail buzz centers on its investigational therapy, Gemini, which received FDA clearance last month for a Phase 1b trial targeting chronic kidney disease patients.&nbsp;However, concerns around the company’s cash burn and financing moves have tempered investor enthusiasm. REVB shares dropped over 90% in 2024, leaving the stock a speculative favorite entering 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off

From acquisition news and FDA designations to fresh optimism for struggling stocks, these biotechs piqued Stocktwits users the most on the first trading day of 2025.

Equity

From acquisition news and FDA designations to fresh optimism for struggling stocks, these biotechs piqued Stocktwits users the most on the first trading day of 2025.


Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its cosmetic product lines include Carmell Secretome and Elevai Exosomes, that support skin and hair health. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.

Longevity Health Holdings Inc.

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$2.31
Prev Close	$2.74
Open	$2.74
Dividend Yield	0.00%
50-Day Moving Average	$0.4186
Beta	0.72
Avg. Volume	4,551.41
PE Ratio	-0.06

52-Week High	$14.55
52-Week Low	$0.2898
Market Capitalization	$558,687.00
EPS (Annual)	-$16.57
Price to Book	-0.14
Revenue Per Employee	$3,354.53
Enterprise Value/EBITDA	N/A

CTCX
Carmell Therapeutics Corp - Ordinary Shares - Class A

Feed

News

Sentiment

Fundamentals

Info

Latest CTCX News

CTCXCarmell Therapeutics Corp - Ordinary Shares - Class A